Our 160+ page report provides 90+ tables, 30+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Cancer Immunotherapy Drug Discovery Outsourcing market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the global market and submarkets
Along with revenue prediction for the overall world market, there are 3 segmentations of the Cancer Immunotherapy Drug Discovery Outsourcing market, with forecasts for 4 Drug Types, 3 Services, 7 Cancer Types, each forecasted at a global and regional level.
Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Drug Type
• Monoclonal Antibodies
• Immunomodulators
• Cancer Vaccines and Oncolytic Therapies
• Others
Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Services
• Target Identification and Validation
• Lead screening and Characterization
• Cell based Assays
Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Melanoma
• Prostate Cancer
• Head and Neck Cancer
• Ovarian Cancer
• Pancreatic Cancer
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:
• North America:
• US
• Canada
• Europe:
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Asia-Pacific:
• Japan
• China
• India
• Australia
• ASEAN
• Rest of Asia-Pacific
• Latin America:
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa:
• UAE
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
The report also includes profiles and for some of the leading companies in the Cancer Immunotherapy Drug Discovery Outsourcing Market, with a focus on this segment of these companies’ operations. There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., UK, Germany, Japan, India and China in particular, will continue to achieve high revenue growth to 2030.
Leading companies and the potential for market growth
Overall world revenue for Cancer Immunotherapy Drug Discovery Outsourcing will surpass $750 million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Cancer Immunotherapy Drug Discovery Outsourcing Market report helps you
In summary, our 160+ page report provides you with the following knowledge:
• Revenue forecasts to 2030 for 3 segmentations of the Cancer Immunotherapy Drug Discovery Outsourcing market, with forecasts for 4 Drug Types, 3 Services, 7 Cancer Types, each forecasted at a global and regional level–discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 18 key national markets – See forecasts for the Cancer Immunotherapy Drug Discovery Outsourcing market in North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, ASEAN countries, UAE, South Africa and Saudi Arabia.
• Stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market– including company profiles for 14 of the major companies involved in the Cancer Immunotherapy Drug Discovery Outsourcing market
• Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain study is for everybody needing commercial analyses for the Cancer Immunotherapy Drug Discovery Outsourcing market and leading companies. You will find data, trends and predictions.
Get our report today Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2020-2030: Prospects by Drug Type (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Therapies, Others), Services (Target Identification and Validation, Lead Screening and Characterization, Cell Based Assays), Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer), and Geography.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Includes
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction
2.1 Objectives of the Study
2.2 Market Definition
2.3 Market Scope
2.4 Markets Covered
2.5 Years Considered for the Study
2.6 Limitations
2.7 Currency
3. Industry Insights
3.1 Market Drivers
3.1.1 Rising awareness regarding advancements in cancer immunotherapy
3.1.2 Growing investments by pharmaceutical companies in outsourcing
3.1.3 Potential alternative treatment for cancer
3.1.4 Growing clinical trials and R&D
3.1.5 Low risk of tumor reoccurrence, post chemotherapy
3.2 Market Restraints/Challenges
3.2.1 Costly immunotherapy treatment
3.2.2 Quality issues involved with drug discovery CRO services
3.2.3 Intellectual property right issues
3.3 Market Opportunities
3.3.1 Emerging Markets
3.3.2 Introduction of novel & advanced immunotherapy drugs in Asia Pacific
3.4 Value chain analysis
3.5 SWOT analysis (qualitative insights)
3.5.1 SWOT analysis – A detailed analysis of the global market strengths, weakness, opportunities and threats.
3.5.2 Market Strength
3.5.3 Market Weakness
3.5.4 Market Opportunities
3.5.5 Market Threats
3.5.6 Progression of key events associated with the market
3.6 PEST analysis (qualitative insights)
3.6.1 Political factors
3.6.1.1 Description and overview of political factors
3.6.1.2 Definition and identification of relevant political factors
3.6.1.3 Political concerns
3.6.1.4 Reforms and Regulations
3.6.1.5 Political stability
3.6.2 Economic factors
3.6.2.1 Definition and identification of economic factors
3.6.2.2 Description and overview of economic factors
3.6.2.3 Economic concerns
3.6.2.4 Economic value
3.6.2.5 Resource efficiency
3.6.3 Social factors
3.6.3.1 Description and overview of social factors
3.6.3.2 Definition and identification of social factors
3.6.3.3 Social concerns
3.6.3.4 Knowledge and skills
3.6.4 Technological factors
3.6.4.1 Description and overview of technological factors
3.6.4.2 Definition and identification of technological factors
3.6.4.3 Technological concerns
3.7 Porters Five Forces Model (qualitative insights)
3.7.1 Intensity of Competitive Rivalry
3.7.1.1 Diversity of competitors
3.7.1.2 Industry concentration
3.7.1.3 Industry growth
3.7.1.4 Number of competitors
3.7.1.5 Switching costs
3.7.2 Threat of Substitutes
3.7.2.1 Buyer propensity to substitute
3.7.2.2 Relative price performance of substitutes
3.7.2.3 Switching costs
3.7.2.4 Relative price performance of substitute
3.7.3 Bargaining Power of Buyers
3.7.3.1 Ability to backward integrate
3.7.3.2 Brand identity impact on quality/performance
3.7.3.3 Buyer concentration versus firm concentration
3.7.3.4 Buyer switching costs relative to firm switching costs
3.7.4 Bargaining Power of Suppliers
3.7.4.1 Importance of volume to supplier
3.7.4.2 Presence of substitute inputs
3.7.4.3 Supplier concentration
3.7.4.4 Switching cost of suppliers and firms in the industry
3.7.4.5 Threat of forward integration relative to threat of backward integration by firms in the industry
3.7.5 Threat of New Entrants
3.7.5.1 Access to distribution channel
3.7.5.2 Barriers to entry
3.7.5.3 Brand loyalty
3.7.5.4 Capital requirements
3.7.5.5 Economies of scale
3.7.5.6 Government policies
3.7.5.7 Switching costs
4. Global Cancer Immunotherapy Drug Discovery Outsourcing market – By Drug Type
4.1 Monoclonal Antibodies
4.1.1 Market size and forecast, 2020-2030 (USD Million)
4.2 Immunomodulators
4.2.1 Market size and forecast, 2020-2030 (USD Million)
4.3 Cancer Vaccines and Oncolytic Therapies
4.3.1 Market size and forecast, 2020-2030 (USD Million)
4.4 Others
4.4.1 Market size and forecast, 2020-2030 (USD Million)
5. Global Cancer Immunotherapy Drug Discovery Outsourcing market – By Services
5.1 Target Identification and Validation
5.1.1 Market size and forecast, 2020-2030 (USD Million)
5.2 Lead screening and Characterization
5.2.1 Market size and forecast, 2020-2030 (USD Million)
5.3 Cell based Assays
5.3.1 Market size and forecast, 2020-2030 (USD Million)
6. Global Cancer Immunotherapy Drug Discovery Outsourcing market – By Cancer Type
6.1 Lung Cancer
6.1.1 Market size and forecast, 2020-2030 (USD Million)
6.2 Breast Cancer
6.2.1 Market size and forecast, 2020-2030 (USD Million)
6.3 Colorectal Cancer
6.3.1 Market size and forecast, 2020-2030 (USD Million)
6.4 Melanoma
6.4.1 Market size and forecast, 2020-2030 (USD Million)
6.5 Prostate Cancer
6.5.1 Market size and forecast, 2020-2030 (USD Million)
6.6 Head and Neck Cancer
6.6.1 Market size and forecast, 2020-2030 (USD Million)
6.7 Ovarian Cancer
6.7.1 Market size and forecast, 2020-2030 (USD Million)
6.8 Pancreatic Cancer
6.8.1 Market size and forecast, 2020-2030 (USD Million)
7. By Region
7.1 Introduction
7.2 North America Cancer Immunotherapy Drug Discovery Outsourcing market, 2020-2030 (USD Million)
7.2.1 U.S.
7.2.1.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.2.1.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.2.1.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.2.2 Canada
7.2.2.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.2.2.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.2.2.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing market, 2020-2030 (USD Million)
7.3.1 Germany
7.3.1.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.3.1.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.3.1.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.3.2 France
7.3.2.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.3.2.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.3.2.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.3.3 UK
7.3.3.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.3.3.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.3.3.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.3.4 Italy
7.3.4.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.3.4.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.3.4.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.3.5 Spain
7.3.5.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.3.5.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.3.5.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.3.6 Russia
7.3.6.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.3.6.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.3.6.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.3.7 Rest of Europe
7.3.7.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.3.7.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.3.7.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.4 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing market, 2020-2030 (USD Million)
7.4.1 Japan
7.4.1.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.4.1.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.4.1.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.4.2 China
7.4.2.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.4.2.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.4.2.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.4.3 India
7.4.3.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.4.3.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.4.3.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.4.4 Australia
7.4.4.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.4.4.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.4.4.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.4.5 ASEAN
7.4.5.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.4.5.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.4.5.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.4.6 Rest of Asia Pacific
7.4.6.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.4.6.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.4.6.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.5 Latin America Cancer Immunotherapy Drug Discovery Outsourcing market, 2020-2030 (USD Million)
7.5.1 Brazil
7.5.1.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.5.1.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.5.1.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.5.2 Mexico
7.5.2.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.5.2.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.5.2.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.5.3 Rest of Latin America
7.5.3.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.5.3.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.5.3.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.6 Middle East Cancer Immunotherapy Drug Discovery Outsourcing market, 2020-2030 (USD Million)
7.6.1 UAE
7.6.1.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.6.1.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.6.1.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.6.2 Saudi Arabia
7.6.2.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.6.2.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.6.2.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.6.3 South Africa
7.6.3.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.6.3.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.6.3.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
7.6.4 Rest of Middle East & Africa
7.6.4.1 Market Size & Forecast, By Drug Type, 2020-2030 (USD Million)
7.6.4.2 Market Size & Forecast, By Services, 2020-2030 (USD Million)
7.6.4.3 Market Size & Forecast, By Cancer Type, 2020-2030 (USD Million)
8. Competitive Landscape
8.1 Competitive environment
8.2 New product development
8.3 Merger & acquisitions
8.4 Strategic framework
9. Leading Companies
9.1 Aquila Biomedical
9.1.1 Company Overview
9.1.2 Product Offerings
9.1.3 Financial Performance (2016-2018)
9.1.4 Recent Initiatives
9.2 BPS Biosciences Inc.
9.2.1 Company Overview
9.2.2 Product Offerings
9.2.3 Financial Performance (2016-2018)
9.2.4 Recent Initiatives
9.3 Celentyx Ltd.
9.3.1 Company Overview
9.3.2 Product Offerings
9.3.3 Financial Performance (2016-2018)
9.3.4 Recent Initiatives
9.4 Covance, Inc
9.4.1 Company Overview
9.4.2 Product Offerings
9.4.3 Financial Performance (2016-2018)
9.4.4 Recent Initiatives
9.5 Crown Bioscience Inc.
9.5.1 Company Overview
9.5.2 Product Offerings
9.5.3 Financial Performance (2016-2018)
9.5.4 Recent Initiatives
9.6 Explicit Immuno-Oncology
9.6.1 Company Overview
9.6.2 Product Offerings
9.6.3 Financial Performance (2016-2018)
9.6.4 Recent Initiatives
9.7 Gen script Biotech Corporation
9.7.1 Company Overview
9.7.2 Product Offerings
9.7.3 Financial Performance (2016-2018)
9.7.4 Recent Initiatives
9.8 HD Biosciences Co. Ltd.
9.8.1 Company Overview
9.8.2 Product Offerings
9.8.3 Financial Performance (2016-2018)
9.8.4 Recent Initiatives
9.9 Horizon Discovery Group plc
9.9.1 Company Overview
9.9.2 Product Offerings
9.9.3 Financial Performance (2016-2018)
9.9.4 Recent Initiatives
9.10 ImmuneXperts SA
9.10.1 Company Overview
9.10.2 Product Offerings
9.10.3 Financial Performance (2016-2018)
9.10.4 Recent Initiatives
9.11 Molecular Imaging Inc. (MI Bioresearch Inc.)
9.11.1 Company Overview
9.11.2 Product Offerings
9.11.3 Financial Performance (2016-2018)
9.11.4 Recent Initiatives
9.12 Personalis, Inc.
9.12.1 Company Overview
9.12.2 Product Offerings
9.12.3 Financial Performance (2016-2018)
9.12.4 Recent Initiatives
9.13 Promega Corporation
9.13.1 Company Overview
9.13.2 Product Offerings
9.13.3 Financial Performance (2016-2018)
9.13.4 Recent Initiatives
9.14 STC Biologics
9.14.1 Company Overview
9.14.2 Product Offerings
9.14.3 Financial Performance (2016-2018)
9.14.4 Recent Initiatives
10. Appendix
10.1 Insights of Industry Experts
10.2 Related Reports
10.3 Author Details
10.4 Available Customizations
LIST OF TABLES
Table 1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Region, 2020-2030 (USD Mn, CAGR%)
Table 2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 5 North America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 6 North America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 7 North America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 8 North America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 9 US: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 10 US: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 11 US: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 12 Canada: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 13 Canada: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 14 Canada: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 15 Europe: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 16 Europe: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 17 Europe: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 18 Europe: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 19 Germany: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 20 Germany: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 21 Germany: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 22 France: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 23 France: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 24 France: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 25 UK: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 26 UK: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 27 UK: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 28 Italy: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 29 Italy: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 30 Italy: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 31 Spain: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 32 Spain: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 33 Spain: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 34 Russia: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 35 Russia: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 36 Russia: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 37 Rest of Europe: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 38 Rest of Europe: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 39 Rest of Europe: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 40 Asia-Pacific: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 41 Asia-Pacific: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 42 Asia-Pacific: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 43 Asia-Pacific: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 44 Japan: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 45 Japan: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 46 Japan: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 47 China: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 48 China: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 49 China: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 50 India: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 51 India: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 52 India: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 53 Australia: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 54 Australia: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 55 Australia: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 56 ASEAN: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 57 ASEAN: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 58 ASEAN: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 59 Rest of Asia Pacific: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 60 Rest of Asia Pacific: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 61 Rest of Asia Pacific: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 62 Latin America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 63 Latin America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 64 Latin America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 65 Latin America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 66 Brazil: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 67 Brazil: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 68 Brazil: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 69 Mexico: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 70 Mexico: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 71 Mexico: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 72 Rest of Latin America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 73 Rest of Latin America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 74 Rest of Latin America: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 75 Middle East & Africa: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 76 Middle East & Africa: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 77 Middle East & Africa: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 78 Middle East & Africa: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 79 UAE: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 80 UAE: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 81 UAE: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 82 Saudi Arabia: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 83 Saudi Arabia: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 84 Saudi Arabia: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 85 South Africa: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 86 South Africa: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 87 South Africa: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
Table 88 Rest of Middle East & Africa: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type, 2020-2030 (USD Mn, CAGR%)
Table 89 Rest of Middle East & Africa: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Services, 2020-2030 (USD Mn, CAGR%)
Table 90 Rest of Middle East & Africa: Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Cancer Type, 2020-2030 (USD Mn, CAGR%)
LIST OF FIGURES
Figure 1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation
Figure 2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Market Dynamics
Figure 3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Porter’s analysis
Figure 4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market PEST analysis
Figure 5 Drivers, Restraints, Opportunities, and Challenges in the Global Cancer Immunotherapy Drug Discovery Outsourcing Market
Figure 6 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type, 2020-2030 (USD Mn)
Figure 7 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Services, 2020-2030 (USD Mn)
Figure 8 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type, 2020-2030 (USD Mn)
Figure 9 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region, 2018 & 2030 (%)
Figure 10 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Country, 2018 & 2030 (%)
Figure 11 U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 12 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 13 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Country, 2018 & 2030 (%)
Figure 14 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 15 UK Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 16 France Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 17 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 18 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 19 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 20 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 21 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Country, 2018 & 2030 (%)
Figure 22 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 23 China Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 24 Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 25 ASEAN Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 26 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 27 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Country, 2018 & 2030 (%)
Figure 28 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 29 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 30 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 31 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Country, 2018 & 2030 (%)
Figure 32 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 33 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 34 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 35 Rest of Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, 2020-2030 (USD Mn)
Figure 36 Company Share Analysis, 2018
Figure 37 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Rate